Hepatoma Research
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Hepatoma Research
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig4

From:  Oncologic outcomes and rates of hepatotoxicity following stereotactic body radiotherapy for hepatocellular carcinoma
Oncologic outcomes and rates of hepatotoxicity following stereotactic body radiotherapy for hepatocellular carcinoma

Figure 4. Change in liver function after SBRT. Change in CP score is displayed for patients with available data at 3 (A) and 6 months (B) following SBRT. Change in ALBI grade is displayed at 3 (C) and 6 months (D) following SBRT. ALBI: Albumin-bilirubin Score; CP: child-pugh; SBRT: stereotactic body radiotherapy.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties